Ambu A/S (FRA:547A)

Market Cap	3.03B -37.6%
Revenue (ttm)	808.32M +12.0%
Net Income	81.54M +159.1%
EPS	0.31 +159.1%
Shares Out	n/a
PE Ratio	37.14
Forward PE	34.50
Dividend	0.05 (0.49%)
Ex-Dividend Date	Dec 4, 2025

Volume	n/a
Average Volume	n/a
Open	11.29
Previous Close	11.35
Day's Range	11.29 - 11.29
52-Week Range	10.95 - 19.02
Beta	n/a
RSI	41.08
Earnings Date	Feb 4, 2026

About Ambu A/S

Ambu A/S, together with its subsidiaries, researches, develops, manufactures, markets, and sells medical technology solutions in North America, Europe, and internationally. The company offers endoscopy products, including bronchoscopes, video laryngoscopes, rhinolaryngoscopes, duodenoscopes, gastroscopes, cystoscopes, ureteroscopes, and displaying and processing units; neurology products, such as EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products; and cardiology products comprising ECG electrodes. It also prov...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 1937
• Employees: 5,384
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 547A

Financial Performance

In fiscal year 2025, Ambu A/S's revenue was 6.04 billion, an increase of 11.98% compared to the previous year's 5.39 billion. Earnings were 609.00 million, an increase of 159.15%.

Financial numbers in DKK